Loss of blood group according to blood group and patient diagnosis
| Diagnosis . | Blood group . | Loss of A or B . | Loss of H . | Loss of A or B and H . | No loss . | Total . |
|---|---|---|---|---|---|---|
| AML | A, B | 3 | 3 | 2 | 8 | 16 |
| O | NA | 6 | NA | 16 | 22 | |
| MPD | A, B, AB | 1 | 1 | 0 | 3 | 5 |
| O | NA | 0 | NA | 1 | 1 | |
| MDS | A, B, AB | 4 | 1 | 1 | 2 | 8 |
| O | NA | 0 | NA | 5 | 5 | |
| Total | 8 | 11 | 3 | 35 | 57 |
| Diagnosis . | Blood group . | Loss of A or B . | Loss of H . | Loss of A or B and H . | No loss . | Total . |
|---|---|---|---|---|---|---|
| AML | A, B | 3 | 3 | 2 | 8 | 16 |
| O | NA | 6 | NA | 16 | 22 | |
| MPD | A, B, AB | 1 | 1 | 0 | 3 | 5 |
| O | NA | 0 | NA | 1 | 1 | |
| MDS | A, B, AB | 4 | 1 | 1 | 2 | 8 |
| O | NA | 0 | NA | 5 | 5 | |
| Total | 8 | 11 | 3 | 35 | 57 |
Patients were classified according to disease: acute myeloid leukemia (AML); myeloproliferative disorder (MPD), including chronic myeloid leukemia (CML); and myelodysplastic syndrome (MDS), including chronic myelomonocytic leukemia (CMML). NA (not applicable) refers to the O blood group where loss of A or B antigens could not be assessed.